<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

	<!-- RSS feed defaults -->
	<channel>
		<title>Wyss InstituteTissue Engineering &#8211; Wyss Institute</title>
		<link>https://wyss.stage.a17.io</link>
		<description>Wyss Institute at Harvard</description>
		<lastBuildDate>Thu, 30 Jul 2026 21:38:59 +0000</lastBuildDate>
		<language>en-US</language>
		<sy:updatePeriod>hourly</sy:updatePeriod>
		<sy:updateFrequency>1</sy:updateFrequency>
		<atom:link href="https://wyss.stage.a17.io/discipline/tissue-engineering/feed/" rel="self" type="application/rss+xml" />

		<generator>https://wordpress.org/?v=6.9.6</generator>

		<!-- Start loop -->
		
			<item>
				<title>20ish Questions with Elliot Chaikof</title>
				<link>https://wyss.stage.a17.io/media-post/20ish-questions-with-elliot-chaikof/</link>
        <pubDate>Tue, 17 Dec 2024 14:00:23 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Beth Israel Deaconess Medical Center]]></category>
		<category><![CDATA[Community]]></category>
		<category><![CDATA[Elliot L. Chaikof]]></category>
		<category><![CDATA[Vasculature]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?post_type=media_post&#038;p=41628</guid>
                                                <content:encoded><![CDATA[<p>20&#x2d;ish Questions shows a different side of Wyss Institute faculty, touching on aspects of their personal life, hobbies, interests, as well as their research. This round follows Elliot Chaikof, an Associate Faculty member at the Wyss Institute as well as the Chair of the Department of Surgery &amp; Surgeon&#x2d;in&#x2d;Chief at Beth Israel Deaconess Medical Center. Credit: Wyss Institute at Harvard University&#8230;</p>
<p><a href="https://wyss.stage.a17.io/media-post/20ish-questions-with-elliot-chaikof/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/media-post/20ish-questions-with-elliot-chaikof/</link>
          <title></title>
					<url>https://wyss-stage.imgix.net/app/uploads/2024/12/05124139/THUMBNAIL_20-ish-Questions-with-Elliot-Chaikof_No-Text.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=bbb014e84c92ba022e293e644ec18683"/></url>
				</image>
        			</item>

		
			<item>
				<title>Innovative tissue engineering: ESCAPE, a pioneering new method explained</title>
				<link>https://wyss.stage.a17.io/news/innovative-tissue-engineering-escape-a-pioneering-new-method-explained/</link>
        <pubDate>Wed, 11 Dec 2024 16:00:31 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Boston University]]></category>
		<category><![CDATA[Christopher Chen]]></category>
		<category><![CDATA[Heart]]></category>
		<category><![CDATA[Implants]]></category>
		<category><![CDATA[Vasculature]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=41664</guid>
                            <description>Molding complex tissues using gallium</description>
                                        <content:encoded><![CDATA[<p>By Boston University Communications (BOSTON) &mdash; When it comes to the human body, form and function work together. The shape and structure of our hands enable us to hold and manipulate things. Tiny air sacs in our lungs called alveoli allow for air exchange and help us breath in and out. And tree&#x2d;like blood vessels branch throughout our body, delivering oxygen from our head to our toes.</p>
<p><a href="https://wyss.stage.a17.io/news/innovative-tissue-engineering-escape-a-pioneering-new-method-explained/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/innovative-tissue-engineering-escape-a-pioneering-new-method-explained/</link>
          <title></title>
					<url>https://wyss-stage.imgix.net/app/uploads/2024/12/10165502/12_Cast-with-ring_CROP.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=973cd27dff9e57118ca795750c18a7fa"/></url>
				</image>
        			</item>

		
			<item>
				<title>ESCAPE Bioengineering</title>
				<link>https://wyss.stage.a17.io/media-post/escape-bioengineering/</link>
        <pubDate>Wed, 11 Dec 2024 16:00:06 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Boston University]]></category>
		<category><![CDATA[Christopher Chen]]></category>
		<category><![CDATA[Heart]]></category>
		<category><![CDATA[Implants]]></category>
		<category><![CDATA[Vasculature]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?post_type=media_post&#038;p=41676</guid>
                                                <content:encoded><![CDATA[<p>A research team at the Wyss Institute and Boston University has developed ESCAPE, the first method that enables the engineering of tissues across multiple length scales, ranging from the diameter of a cell to the cm scale of a heart valve. Credit: Wyss Institute at Harvard University&#8230;</p>
<p><a href="https://wyss.stage.a17.io/media-post/escape-bioengineering/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/media-post/escape-bioengineering/</link>
          <title></title>
					<url>https://wyss-stage.imgix.net/app/uploads/2024/12/11082233/THUMBNAIL_Escape-Bioengineering_No-Text.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=3670be8864105a406ec4c303a084839d"/></url>
				</image>
        			</item>

		
			<item>
				<title>Gozde Basara on Engineering Safer Solutions for Cancer Survivors</title>
				<link>https://wyss.stage.a17.io/news/humans-of-the-wyss-gozde-basara-on-engineering-safer-solutions-for-cancer-survivors/</link>
        <pubDate>Wed, 20 Nov 2024 16:22:50 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Community]]></category>
		<category><![CDATA[Humans of the Wyss]]></category>
		<category><![CDATA[Women's Health]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=41500</guid>
                                                <content:encoded><![CDATA[<p>The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as professionals, and their collaborations at the Wyss Institute and beyond. Gozde Basara has never shied away from learning something new. From starting a Ph.D. in 3D Bioprinting as a mechanical engineer with no advanced knowledge of biology to taking on new artistic&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/humans-of-the-wyss-gozde-basara-on-engineering-safer-solutions-for-cancer-survivors/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/humans-of-the-wyss-gozde-basara-on-engineering-safer-solutions-for-cancer-survivors/</link>
          <title>Gozde Basara, Biofabrication Engineer. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2024/11/18153347/HoW-Gozde-Basara-04067.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=792acff42c7946fa6349136d642d74d5"/></url>
				</image>
        			</item>

		
			<item>
				<title>Wyss Institute’s iNodes team receives ARPA-H Sprint for Women’s Health award to advance the first implantable immune organs to treat ovarian cancer</title>
				<link>https://wyss.stage.a17.io/news/inodes-receives-arpa-h-award/</link>
        <pubDate>Tue, 12 Nov 2024 14:58:41 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Awards]]></category>
		<category><![CDATA[Community]]></category>
		<category><![CDATA[Donald E. Ingber]]></category>
		<category><![CDATA[Immune System]]></category>
		<category><![CDATA[Women's Health]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=41442</guid>
                            <description>iNodes is a new treatment paradigm in personalized immunotherapy with the potential to prolong the lives of many patients with advanced ovarian cancer </description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; Ovarian cancer is more deadly than any other type of female reproductive organ cancer. It is estimated that in 2024, in the U.S. alone, more than 12,000 women will die from the disease because available therapies are not effective. To help overcome this striking deficit in women&rsquo;s health, ARPA&#x2d;H has selected a team at the Wyss Institute at Harvard University as&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/inodes-receives-arpa-h-award/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/inodes-receives-arpa-h-award/</link>
          <title>Gigija Goyal, Senior Scientist II. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2022/02/03113258/WoW-Girija-Goyal-Neutral-2081.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=503aad01b8edf087abbae2069ea5b85b"/></url>
				</image>
        			</item>

		
			<item>
				<title>CRISPR&#8217;s Impact, Today</title>
				<link>https://wyss.stage.a17.io/news/crisprs-impact-today/</link>
        <pubDate>Mon, 21 Oct 2024 12:00:08 +0000</pubDate>
        <dc:creator><![CDATA[Mariel Schoen]]></dc:creator>
        		<category><![CDATA[Translation News]]></category>
		<category><![CDATA[CRISPR]]></category>
		<category><![CDATA[Editas Inc.]]></category>
		<category><![CDATA[eGenesis]]></category>
		<category><![CDATA[George Church]]></category>
		<category><![CDATA[Massachusetts General Hospital]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=40926</guid>
                            <description>Keeping CRISPR’s promise for patients in need</description>
                                        <content:encoded><![CDATA[<p>By Seth Kroll (BOSTON) &mdash; In the not&#x2d;so&#x2d;distant past, CRISPR, the revolutionary gene&#x2d;editing technology, was discovered as a defense system protecting bacteria against viruses. Today, with the persistence and ingenuity of many scientists, it is no longer just the subject of fascinating academic research papers and speculative discussions on its future usefulness for medicine.</p>
<p><a href="https://wyss.stage.a17.io/news/crisprs-impact-today/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/crisprs-impact-today/</link>
          <title>Slayman with (left to right) Dr. Leo Riella, Medical Director of Kidney Transplantation, Dr. Nahel Elias, Interim Chief, Division of Transplant Surgery, his partner, Faren, and Dr. Tatsuo Kawai, Director, Legorreta Center for Clinical Transplant Tolerance. CREDITS: Michelle Rose/Massachusetts General Hospital</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2024/09/09093712/20240403_mcr_transplant_patient_010-1.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=911871f7428259dbd6ffadedb29de92e"/></url>
				</image>
        			</item>

		
			<item>
				<title>Progress, Potential, and Possibilities with Luba Perry, Ph.D. &#8211; Bioengineered Breast Reconstruction And Augmentation</title>
				<link>https://wyss.stage.a17.io/media-post/progress-potential-and-possibilities-with-luba-perry-ph-d-bioengineered-breast-reconstruction-and-augmentation/</link>
        <pubDate>Tue, 08 Oct 2024 14:24:03 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[3D Bioprinting]]></category>
		<category><![CDATA[Organ Engineering]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?post_type=media_post&#038;p=41160</guid>
                                                <content:encoded><![CDATA[<p>Each episode of this podcast includes a discussion with fascinating people designing a better tomorrow. Luba Perry, Ph.D. is Co&#x2d;Founder and CEO of ReConstruct Bio, an innovative venture emerging from Harvard&rsquo;s Wyss Institute, aimed at redefining the fields of medical reconstruction and aesthetics with an initial application of their groundbreaking technology on breast reconstruction and&#8230;</p>
<p><a href="https://wyss.stage.a17.io/media-post/progress-potential-and-possibilities-with-luba-perry-ph-d-bioengineered-breast-reconstruction-and-augmentation/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/media-post/progress-potential-and-possibilities-with-luba-perry-ph-d-bioengineered-breast-reconstruction-and-augmentation/</link>
          <title>Luba Perry, Postdoctoral Fellow. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2021/06/21103731/HoW-Luba-Perry-0740.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=df27314b47a1b42b2a4d8ab4b0e8cd37"/></url>
				</image>
        			</item>

		
			<item>
				<title>Wyss Institute promotes Natalie Artzi to its Core Faculty and appoints Di Feng as an Associate Faculty member</title>
				<link>https://wyss.stage.a17.io/news/wyss-institute-promotes-natalie-artzi-to-its-core-faculty-and-appoints-di-feng-as-an-associate-faculty-member/</link>
        <pubDate>Mon, 12 Aug 2024 13:15:25 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Community]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Beth Israel Deaconess Medical Center]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Brain]]></category>
		<category><![CDATA[Brigham and Women's Hospital]]></category>
		<category><![CDATA[Di Feng]]></category>
		<category><![CDATA[Harvard Medical School]]></category>
		<category><![CDATA[Natalie Artzi]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=40759</guid>
                            <description>Artzi’s promotion and Feng’s appointment strengthen the Institute’s efforts in nanomedicine and immunoengineering, as well as modeling of chronic kidney diseases</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; Natalie Artzi, Ph.D., joined the ranks of the Wyss Institute&rsquo;s now 12 Core Faculty members after only two years as an Associate Faculty member. Artzi&rsquo;s promotion reflects her exceptional commitment to the Institute&rsquo;s mission and the deep engagements and collaborations she has initiated within its technology development community. The Wyss Institute also warmly&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/wyss-institute-promotes-natalie-artzi-to-its-core-faculty-and-appoints-di-feng-as-an-associate-faculty-member/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/wyss-institute-promotes-natalie-artzi-to-its-core-faculty-and-appoints-di-feng-as-an-associate-faculty-member/</link>
          <title>In August, we announced <a href="https://wyss.harvard.edu/news/wyss-institute-promotes-natalie-artzi-to-its-core-faculty-and-appoints-di-feng-as-an-associate-faculty-member/">Natalie Artzi’s promotion to Core Faculty member and the appointment of Di Feng</a> as an Associate Faculty member. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2024/08/08145256/ArtziFengComposite.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=1c298d6dde25ec80aa1f9fe30f99b0fd"/></url>
				</image>
        			</item>

		
			<item>
				<title>3D-printed blood vessels bring artificial organs closer to reality</title>
				<link>https://wyss.stage.a17.io/news/3d-printed-blood-vessels-bring-artificial-organs-closer-to-reality/</link>
        <pubDate>Wed, 07 Aug 2024 16:55:18 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[3D Bioprinting]]></category>
		<category><![CDATA[Bioprinting]]></category>
		<category><![CDATA[Extracellular Matrix]]></category>
		<category><![CDATA[Harvard SEAS]]></category>
		<category><![CDATA[Heart]]></category>
		<category><![CDATA[Jennifer A. Lewis]]></category>
		<category><![CDATA[Organ Engineering]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=40723</guid>
                            <description>New printing method creates branching vessels in heart tissue that replicate the structure of human vasculature in vitro </description>
                                        <content:encoded><![CDATA[<p>By Lindsay Brownell (BOSTON) &mdash; Growing functional human organs outside the body is a long&#x2d;sought &ldquo;holy grail&rdquo; of organ transplantation medicine that remains elusive. New research from Harvard&rsquo;s Wyss Institute for Biologically Inspired Engineering and John A. Paulson School of Engineering and Applied Science (SEAS) brings that quest one big step closer to completion. A team of scientists&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/3d-printed-blood-vessels-bring-artificial-organs-closer-to-reality/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/3d-printed-blood-vessels-bring-artificial-organs-closer-to-reality/</link>
          <title>A new technique that builds on SWIFT, called co-SWIFT, creates branched vascular channels to more accurately replicate the structure of naturally occurring blood vessels. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2024/08/06114145/printedVesselNetwork.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=5093bd0c1f6aeaa736eaaa9c40b5967c"/></url>
				</image>
        			</item>

		
			<item>
				<title>A model of Collaborative Ethics to guide translational research from fundamental discoveries to real-world applications</title>
				<link>https://wyss.stage.a17.io/news/a-model-of-collaborative-ethics-to-guide-translational-research-from-fundamental-discoveries-to-real-world-applications/</link>
        <pubDate>Tue, 25 Jun 2024 14:55:06 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Biological Materials]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Biosafety]]></category>
		<category><![CDATA[Cell Engineering]]></category>
		<category><![CDATA[George Church]]></category>
		<category><![CDATA[Harvard Medical School]]></category>
		<category><![CDATA[Neurology]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=40318</guid>
                            <description>Multi-stage process driven by close and continued collaboration between scientists and ethicists ensures that new breakthrough technologies are safe and beneficial for all</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; In sciences, disruptive research that is breaking new ground often raises new and not&#x2d;yet&#x2d;explored ethical questions. Although new scientific breakthroughs can have the power to change how we understand and live in the world, the ethical implications of technologies that will emerge based on these new insights can affect an emerging field&rsquo;s public acceptance and&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/a-model-of-collaborative-ethics-to-guide-translational-research-from-fundamental-discoveries-to-real-world-applications/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/a-model-of-collaborative-ethics-to-guide-translational-research-from-fundamental-discoveries-to-real-world-applications/</link>
          <title>02/10/2017  BOSTON, MA    Bioethicist Jeantine Lunshof (cq) poses for a portrait at Harvard Medical School.   (Aram Boghosian for The Boston Globe)</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2019/07/23151323/Jeantine-Lunshof-headshot.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=1d6fdc21b39cb23fd08089bf01d3ec21"/></url>
				</image>
        			</item>

			</channel>
</rss>
